Efficacy and tolerability of using platelet‐rich plasma versus chemical peeling in periorbital hyperpigmentation
Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH. Subjects and methods Forty‐two patients were enrolled...
Saved in:
Published in | Journal of cosmetic dermatology Vol. 18; no. 6; pp. 1680 - 1685 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.
Objective
This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH.
Subjects and methods
Forty‐two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.
Results
Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).
Conclusions
Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP. |
---|---|
AbstractList | Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.
This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH.
Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.
Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).
Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP. Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.BACKGROUNDVarious therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH.OBJECTIVEThis study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH.Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.SUBJECTS AND METHODSForty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).RESULTSFemales constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.CONCLUSIONSBoth PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP. Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH. Subjects and methods Forty‐two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. Results Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). Conclusions Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP. |
Author | Kamel, Noha Ellabban, Noura F. Eyada, Moustafa Nada, Hesham |
Author_xml | – sequence: 1 givenname: Noura F. surname: Ellabban fullname: Ellabban, Noura F. organization: Ministry of Health – sequence: 2 givenname: Moustafa surname: Eyada fullname: Eyada, Moustafa organization: Suez Canal University – sequence: 3 givenname: Hesham surname: Nada fullname: Nada, Hesham organization: Suez Canal University – sequence: 4 givenname: Noha orcidid: 0000-0002-8990-2312 surname: Kamel fullname: Kamel, Noha email: nkamel30@yahoo.com organization: Suez Canal University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31021041$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctu1TAQhi1URC-w4QFQlgjpFE9sJydLdCg3VeoG1pYvkx5XThxspyg7HqHP2CfBh7QsEMIbz4y-_5dm_lNyNIYRCXkJ9BzKe3sTjD2Humv4E3ICvGWbGhpx9Kdm9JicpnRDKbQdiGfkmAGtgXI4IfGi751RZqnUaKscPEalnXd5qUJfzcmN19XkVUaP-f7nXXRmf-jToKpbjGlOldnjUBx8NSH6A-7GUkYXona5jPdL6SZ3PeCYVXZhfE6e9sonfPHwn5FvHy6-7j5tLq8-ft69u9wYVnd8o1FptG3D675hDUOgVljasS0XrbC8Mw3fMo26sVYg04LVWwtbYzSHFnkBz8jr1XeK4fuMKcvBJYPeqxHDnGRdg6AMeCMK-uoBnfWAVk7RDSou8vFOBaArYGJIKWIvjVu3yVE5L4HKQxTyEIX8HUWRvPlL8uj6TxhW-IfzuPyHlF-udu9XzS9uzpxE |
CitedBy_id | crossref_primary_10_1007_s12634_019_0092_x crossref_primary_10_1007_s43032_021_00579_2 crossref_primary_10_1016_j_clindermatol_2021_08_007 crossref_primary_10_3390_cosmetics8020026 crossref_primary_10_25259_JCAS_95_2024 crossref_primary_10_59598_ME_2305_6045_2024_113_4_17_28 crossref_primary_10_1111_jocd_14036 crossref_primary_10_1016_j_sxmr_2020_12_004 crossref_primary_10_1055_s_0041_1725107 crossref_primary_10_1111_jocd_16548 crossref_primary_10_1111_prd_12582 crossref_primary_10_2147_CCID_S453243 crossref_primary_10_1007_s00403_020_02173_z crossref_primary_10_1097_DSS_0000000000004372 crossref_primary_10_1155_dth_9155535 |
Cites_doi | 10.1684/ejd.2014.2267 10.1016/j.ad.2013.12.021 10.1111/j.1524-4725.2011.02065.x 10.1016/j.bjps.2012.11.009 10.3109/14764172.2016.1157363 10.1111/jocd.12478 10.1111/jocd.12044 10.5021/ad.2018.30.5.522 10.3892/ijmm.2012.879 10.1111/jocd.12072 10.1111/dsu.12348 10.4103/0019-5154.127675 10.1111/j.1524-4725.2009.01213.x 10.1111/j.1524-4725.2011.02280.x 10.1016/j.biocel.2003.10.023 10.18282/jsd.v1.i2.29 10.5021/ad.2014.26.3.401 10.4103/0019-5154.185707 |
ContentType | Journal Article |
Copyright | 2019 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/jocd.12964 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-2165 |
EndPage | 1685 |
ExternalDocumentID | 31021041 10_1111_jocd_12964 JOCD12964 |
Genre | article Randomized Controlled Trial Journal Article Comparative Study |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFZJQ AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY Q.N QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM YFH YUY ZZTAW ~IA ~WT AAYXX AGQPQ CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
ID | FETCH-LOGICAL-c3294-beabed7642f6363e10d5d09384575d49c6483beb6dd5e3b5328d18ccb417e4093 |
ISSN | 1473-2130 1473-2165 |
IngestDate | Fri Jul 11 03:29:54 EDT 2025 Thu Apr 03 06:59:03 EDT 2025 Thu Apr 24 23:06:17 EDT 2025 Tue Jul 01 02:37:29 EDT 2025 Wed Jan 22 16:38:00 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | patient satisfaction chemical peel periorbital hyperpigmentation platelet-rich plasma |
Language | English |
License | 2019 Wiley Periodicals, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3294-beabed7642f6363e10d5d09384575d49c6483beb6dd5e3b5328d18ccb417e4093 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-8990-2312 |
PMID | 31021041 |
PQID | 2215031465 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2215031465 pubmed_primary_31021041 crossref_citationtrail_10_1111_jocd_12964 crossref_primary_10_1111_jocd_12964 wiley_primary_10_1111_jocd_12964_JOCD12964 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2019 2019-12-00 2019-Dec 20191201 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of cosmetic dermatology |
PublicationTitleAlternate | J Cosmet Dermatol |
PublicationYear | 2019 |
References | 2009; 35 2018; 17 2016; 1 2014; 3 2013; 39 2013; 66 2013; 12 2004; 36 2014; 26 2014; 59 2014; 24 2014; 13 2018; 30 2012; 29 2016; 61 2015; 106 2012; 38 2011; 37 2016; 18 2016; 9 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 Al‐Shami SH (e_1_2_8_6_1) 2014; 3 Roberts WE (e_1_2_8_11_1) 2014; 13 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 Sarkar R (e_1_2_8_3_1) 2016; 9 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_12_1 |
References_xml | – volume: 13 start-page: 72 year: 2014 end-page: 78 article-title: Assessment of efficacy of platelet‐rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles publication-title: J Cosmet Dermatol – volume: 3 start-page: 87 year: 2014 end-page: 94 article-title: Treatment of periorbital hyperpigmentation using platelet‐rich plasma injections publication-title: Am J Dermatol Venereol – volume: 106 start-page: 104 year: 2015 end-page: 111 article-title: Platelet‐rich plasma: applications in dermatology publication-title: Actas dermo‐sifiliograficas – volume: 36 start-page: 1482 year: 2004 end-page: 1491 article-title: Transforming growth factor‐β1 decreases melanin synthesis via delayed extracellular signal‐regulated kinase activation publication-title: Int J Biochem Cell Biol – volume: 29 start-page: 32 year: 2012 end-page: 36 article-title: Platelet‐rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase‐1 in human skin fibroblasts publication-title: Int J Mol Med – volume: 59 start-page: 151 year: 2014 end-page: 157 article-title: Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders publication-title: Indian J Dermatol – volume: 30 start-page: 522 year: 2018 end-page: 528 article-title: Treatments of infra‐orbital dark circles by various etiologies publication-title: Ann Dermatol – volume: 38 start-page: 623 year: 2012 end-page: 630 article-title: Platelet‐rich plasma combined with fractional laser therapy for skin rejuvenation publication-title: Dermatol Surg – volume: 26 start-page: 401 year: 2014 end-page: 402 article-title: Regression of melasma with platelet‐rich plasma treatment publication-title: Ann Dermatol – volume: 18 start-page: 289 year: 2016 end-page: 292 article-title: Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles publication-title: J Cosmet Laser Ther – volume: 39 start-page: 1903 year: 2013 end-page: 1911 article-title: Epidermal growth factor and epidermal growth factor signaling attenuate laser‐induced melanogenesis publication-title: Dermatol Surg – volume: 9 start-page: 49 year: 2016 end-page: 55 article-title: Periorbital hyperpigmentation: a comprehensive review publication-title: J Clin Aesthet Dermatol – volume: 13 start-page: 472 year: 2014 end-page: 482 article-title: Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment publication-title: J Drugs Dermatol – volume: 61 start-page: 413 year: 2016 end-page: 417 article-title: A comparative study of two modalities, 4% hydroquinone versus 30% salicylic acid in periorbital hyperpigmentation and assessment of quality of life before and after treatment publication-title: Indian J Dermatol – volume: 35 start-page: 1163 year: 2009 end-page: 1171 article-title: Infraorbital dark circles: definition, causes, and treatment options publication-title: Dermatol Surg – volume: 66 start-page: 301 year: 2013 end-page: 311 article-title: The use of platelet‐rich plasma in plastic surgery: a systematic review publication-title: J Plast Reconstr Aesthet Surg – volume: 12 start-page: 204 year: 2013 end-page: 209 article-title: Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles publication-title: J Cosmet Dermatol – volume: 17 start-page: 1 year: 2018 end-page: 8 article-title: Evaluation of carboxytherapy and platelet‐rich plasma in treatment of periorbital hyperpigmentation: a comparative clinical trial publication-title: J Cosmet Dermatol – volume: 24 start-page: 100 year: 2014 end-page: 101 article-title: Effects of platelet‐rich plasma on wrinkles and skin tone in Asian lower eyelid skin: preliminary results from a prospective, randomised, split‐face trial publication-title: Eur J Dermatol – volume: 37 start-page: 1297 year: 2011 end-page: 1303 article-title: Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification publication-title: Dermatol Surg – volume: 1 start-page: 108 year: 2016 end-page: 115 article-title: Treatment of periorbital dark circles: comparative study of chemical peeling with a combination of trichloroacetic acid and lactic acid versus carboxytherapy publication-title: Surg J Dermatol – ident: e_1_2_8_9_1 doi: 10.1684/ejd.2014.2267 – ident: e_1_2_8_7_1 doi: 10.1016/j.ad.2013.12.021 – ident: e_1_2_8_19_1 doi: 10.1111/j.1524-4725.2011.02065.x – ident: e_1_2_8_8_1 doi: 10.1016/j.bjps.2012.11.009 – ident: e_1_2_8_12_1 doi: 10.3109/14764172.2016.1157363 – volume: 3 start-page: 87 year: 2014 ident: e_1_2_8_6_1 article-title: Treatment of periorbital hyperpigmentation using platelet‐rich plasma injections publication-title: Am J Dermatol Venereol – ident: e_1_2_8_4_1 doi: 10.1111/jocd.12478 – ident: e_1_2_8_21_1 doi: 10.1111/jocd.12044 – volume: 13 start-page: 472 year: 2014 ident: e_1_2_8_11_1 article-title: Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment publication-title: J Drugs Dermatol – ident: e_1_2_8_10_1 doi: 10.5021/ad.2018.30.5.522 – ident: e_1_2_8_13_1 doi: 10.3892/ijmm.2012.879 – ident: e_1_2_8_14_1 doi: 10.1111/jocd.12072 – ident: e_1_2_8_16_1 doi: 10.1111/dsu.12348 – ident: e_1_2_8_20_1 doi: 10.4103/0019-5154.127675 – ident: e_1_2_8_2_1 doi: 10.1111/j.1524-4725.2009.01213.x – ident: e_1_2_8_17_1 doi: 10.1111/j.1524-4725.2011.02280.x – ident: e_1_2_8_15_1 doi: 10.1016/j.biocel.2003.10.023 – volume: 9 start-page: 49 year: 2016 ident: e_1_2_8_3_1 article-title: Periorbital hyperpigmentation: a comprehensive review publication-title: J Clin Aesthet Dermatol – ident: e_1_2_8_5_1 doi: 10.18282/jsd.v1.i2.29 – ident: e_1_2_8_18_1 doi: 10.5021/ad.2014.26.3.401 – ident: e_1_2_8_22_1 doi: 10.4103/0019-5154.185707 |
SSID | ssj0017915 |
Score | 2.2610526 |
Snippet | Background
Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.
Objective
This study was designed to compare the efficacy... Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. This study was designed to compare the efficacy and tolerability of... Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.BACKGROUNDVarious therapeutic modalities for periorbital... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1680 |
SubjectTerms | Administration, Cutaneous Adult Blood Transfusion, Autologous - adverse effects Blood Transfusion, Autologous - methods Caustics - administration & dosage Caustics - adverse effects Cheek Chemexfoliation - adverse effects Chemexfoliation - methods chemical peel Female Humans Hyperpigmentation - diagnosis Hyperpigmentation - therapy Injections, Intradermal Lactic Acid - administration & dosage Lactic Acid - adverse effects Male Microinjections Patient Satisfaction periorbital hyperpigmentation Photography Platelet-Rich Plasma Skin - diagnostic imaging Skin - drug effects Treatment Outcome Trichloroacetic Acid - administration & dosage Trichloroacetic Acid - adverse effects Young Adult |
Title | Efficacy and tolerability of using platelet‐rich plasma versus chemical peeling in periorbital hyperpigmentation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.12964 https://www.ncbi.nlm.nih.gov/pubmed/31021041 https://www.proquest.com/docview/2215031465 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9owELYoK1W9VH2XvuSqvbQoCCdOQo7VblZotcAFKm5R_EgXiTwU4LD76zu2kxAKW217iYJl7MjzeTzjeSH0VdospolIrIQOuQXyv2ONYGNZSQK6BLE9SXUc92TqjRf0aukuO52i5bW027IBvzsZV_I_VIU2oKuKkv0HyjaDQgO8A33hCRSG54NoHKr8D6peu3aDzNeyNFm3tdV8p28BijUIk0AbC_jdjfq1SeO-csXYbfq8ThZQSBOVrj3Ky1VespWOkQQdtSxWv9IqPim7R5Ll-SZVsZB9odj89uCiPlQwY-aWdQp_ifeuxOFtLLToOslVFFfSHBDTqn2szFFpcyTEqfEomOY3cfuyggQtxw_DX6nvWDYx5SEG8kTbEVP-g8MSz1R-uo_151wMiLIl7w-42qg_nUWXi-vraB4u54_QmQ2Khd1FZ7OfYXjRWJ78QFe9aD6qSmmrvb-asQ-FmCPN5FDR0ZLK_Bl6WhEG_zB4eY46MnuBHk8qJ4qXqKhhgwE2uA0bnCdYwwYfwAYb2GADG1zDBlewwasMt2CDj2DzCi0uw_n52KoKb1jcsQNqMRkzKXxQTRPP8RxJhsIVw8AZURDuBQ24B3uaSeYJ4UqHuY49EmTEOaPElxQ6vkbdLM_kW-U5FzBQ4ihh6iKABsz1EmY7PpHKQMvdHvpWr2TEq6z0qjjKOmq0U1j1SK96D31p-hYmF8vJXp9rgkTAKpX9K84kADmyQbxV1Ro8mPWNoVQzjqNK3A8p6aHvmnR_mSC6mp1f6Ld3D5jqPXqy3wgfUHdb7uRHkGO37FMFvd_dSaMH |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+tolerability+of+using+platelet-rich+plasma+versus+chemical+peeling+in+periorbital+hyperpigmentation&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Ellabban%2C+Noura+F&rft.au=Eyada%2C+Moustafa&rft.au=Nada%2C+Hesham&rft.au=Kamel%2C+Noha&rft.date=2019-12-01&rft.issn=1473-2165&rft.eissn=1473-2165&rft.volume=18&rft.issue=6&rft.spage=1680&rft_id=info:doi/10.1111%2Fjocd.12964&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon |